Clinical Trials
3 trialsNCT00268476 2023-04-18
STAMPEDE
Medical Research Council
Phase 2/3 Active not recruiting
NCT00006124 2013-02-13
Celecoxib in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT00136487 2009-12-09
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
Dana-Farber Cancer Institute
Phase 2/3 Completed